F
Fu-Sheng Wang
Researcher at Chinese PLA General Hospital
Publications - 372
Citations - 29480
Fu-Sheng Wang is an academic researcher from Chinese PLA General Hospital. The author has contributed to research in topics: Medicine & Immune system. The author has an hindex of 61, co-authored 297 publications receiving 21496 citations. Previous affiliations of Fu-Sheng Wang include Chinese Center for Disease Control and Prevention & Fourth Military Medical University.
Papers
More filters
Journal ArticleDOI
Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection.
Ming Shi,Junliang Fu,Feng Shi,Bin Zhang,Zirong Tang,Lei Jin,Zhen-Ping Fan,Zheng Zhang,Liming Chen,Huifeng Wang,George K. K. Lau,Fu-Sheng Wang +11 more
TL;DR: Functional CIK cells were efficiently generated from 21 CHB patients and were transfused in an autologous manner and displayed substantial proliferation and function, and this protocol represents an alternative immune therapeutic strategy for the disease.
Journal ArticleDOI
Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants — China, May 21, 2021–February 28, 2022
Mingshuang Li,Qian-ying Liu,Dan Wu,Li Tang,Xiaoqi Wang,T. Yan,Zhijie An,Zundong Yin,Ge Gao,Fu-Sheng Wang +9 more
TL;DR: Full vaccination and booster vaccination were associated with protection from pneumonia and risk of serious COVID-19 caused by Omicron variant infection, and the pace of booster dose administration, especially among the elderly, should be accelerated.
Journal ArticleDOI
Effects of heat shock protein gp96 on human dendritic cell maturation and CTL expansion.
Yuxia Zhang,Yanlu Zan,Ming Shan,Chang-Mei Liu,Ming Shi,W. Li,Z. Zhang,N. Liu,Fu-Sheng Wang,Weidong Zhong,Fulian Liao,George F. Gao,Po Tien +12 more
TL;DR: In HLA-A2.1/Kb transgenic mice, gp96 and the recombinant fragments were found to augment CTL response specific for the HBcAg(18-27) FLPSDFFPSV peptide of hepatitis B virus.
Journal ArticleDOI
The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope.
Heng-Gui Liu,Weiwei Chen,Zhen-Ping Fan,Hui-ying Yang,Ming Shi,Zheng Zhang,Shen-Shun Luan,Hui Zhang,Peng Lu,Po Tien,Fu-Sheng Wang +10 more
TL;DR: The mutant peptide (FLPSDFFPSI, I27) was found to bind to the HLA-A2 molecule with high affinity and elicit specific cytotoxic T lymphocyte (CTL) responses in acutely infected hepatitis B patients.
Journal ArticleDOI
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL study.
Lai Wei,Ji Dong Jia,Fu-Sheng Wang,Jun Qi Niu,Xu Min Zhao,Shengmei Mu,Li Wen Liang,Zaiqi Wang,Peggy Hwang,Michael N. Robertson,Paul Ingravallo,Ernest Asante-Appiah,Bo Wei,Barbara Evans,George J. Hanna,Rohit Talwani,Zhong Ping Duan,K. V. Zhdanov,Pin-Nan Cheng,Tawesak Tanwandee,Van Kinh Nguyen,Jeong Heo,Vasily Isakov,Jacob George +23 more
TL;DR: Evaluation of efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus infection from Asia–Pacific countries and Russia (C‐CORAL).